a4cell’s Post

Excited to be attending ECCMID 2024 in Barcelona! Looking forward to finding out about the latest advancements in diagnostics and clinical microbiology and catching up with some of you. If you are planning on attending, let's connect over coffee.☕ Although, let's not forget it is Barcelona - I'm partial to pinchos and the Gothic Quarter. 💡 Drop me a message to arrange a meetup and make the most of this fantastic event! #ECCMID2024 #ECCMID #ClinicalMicrobiology"

If you are heading to #ECCMID2024, speak to my colleague Iskandar Vasiev for all things product development in #diagnostics and #microbiology

We're here at the 35th International Symposium on ALS/MND... Our team are all set up at Booth 11 and ready for the influx of scientists, industry experts and members of the community at large who are about to flood through the doors of the Palais des Congres de Montreal. Don't forget to come say hello to us, we'd love to hear from you and possibly get the chance to shed more light about the possibilities that come with iPSCs in transforming ALS research and drug discovery. We will also be presenting a poster where we will be sharing characterization data we have done with our iPSC-derived motor neuron disease model for ALS as part of the ongoing effort to build a better human-relevant model of this disease: Poster: Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery, presented by Adele Etienne Our team will be on Booth 11 so come and talk to us if you are interested in seeing some of this characterization data and hearing how our axoCells can support your ALS research needs. We are also running a 2-min survey where you as members of the ALS community, will be able to help shape the next generation of ALS models. We value your feedback and look forward to using it to develop more sophisticated and more human-relevant iPSC-fuelled models to support ALS drug discovery. To complete this short survey, click here: https://hubs.la/Q02-L3WY0 If you won't be at this event, you can also email us your questions at operations@axolbio.com. We'd be happy to help. See you at Booth 11! #ALSMontreal #humaniPSCs #drugdiscovery #collaboration

It was worthwhile waiting for the outstanding topic on every #DMDG Open Meeting, The Debate, this year the motion was: "This house believes that human will be the only species in DMPK evaluation by the 65th Open Meeting" Speakers FOR the motion: Beth Williamson PhD and Ian Wilson Speakers AGAINST the motion: Toby Athersuch and Steve Hood Moderator: Simon Taylor No doubt that I am FOR the motion since TNO is adhering to the 3R’s principle by offering predictive in vitro and ex vivo platforms predicting human PK/metabolism. Besides the pay-off of our TNO spin-off Peregrion is: Human first, human only. Generating hADME data early in #DrugDevelopment #TNO #Peregrion #DMPK #DrugMetabolism #3Rs

The preliminary results of Daan van Valkengoed from coordinator Elizabeth (Liesbeth) De Lange's group at Universiteit Leiden are quite promising but still confidential, so stay tuned for the real thing in the coming months 😉 . Despite only working on #QSPainrelief for about a year, he already gave a very intriguing ECS Short Talk on translating in vitro data on drug transport into in vivo predictions of #CNS #pharmacokinetics. Great job, Daan! #ChronicPain #PainRelief European Health and Digital Executive Agency (HaDEA) Pain Alliance Europe European Pain Federation EFIC Societal Impact of Pain (SIP) European College of Neuropsychopharmacology (ECNP) Other current QSPainRelief consortium members: Dr. Sara Stöber Andrea Bedini Monica Baiula Chiara Cimetti Divakar Budda Elisabetta Cuna Jessica Jones Solenn Gousset André Mouraux Beltrán Álvarez Pérez Rafael Maldonado Jesús Giraldo Pedro Renault Coen van Hasselt Jeroen Elassaiss-Schaap Petri Takkala Wouter Bakker Geert Jan Groeneveld Scientific and Ethical Advisory Board (SEAB) members: Jan Freijer Dr. Petra Bloms-Funke Nadia Malliou

👩🔬 𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭𝐬, 𝐣𝐨𝐢𝐧 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐧𝐝 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐦𝐨𝐧𝐭𝐡 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐓𝐮𝐦𝐨𝐫 𝐌𝐨𝐝𝐞𝐥𝐬 𝐒𝐮𝐦𝐦𝐢𝐭! This year, we will be presenting on "Mouse Models to Study Mechanisms of Drug Resistance in Immunotherapies and ADCs." Reach out to Jun Wang, Amanda (Mandy) Haltom, PhD, PMP, or Andrew P. if you will be in the area and want to meet before, during, or after the show! More details to come in the next two weeks. #TumorModels #TumorModelsSF #ADCs #PDX #CDX #Immunotherapy

We're peresent at the ACS Conference! Representing us at the event is Kishore V Renduchintala, Our Executive Vice President & Head of Discovery Services and Vidya Sagar K. - Head of Business Development - Discovery Services. Meet us at the ACS Conference to learn more about Laxai and explore a partnership that could revolutionise the approach to drug discovery and development. To book a meeting, reach out to bd@laxai.com. We look forward to connecting with you at the event! hashtag #ACSConference #LAXAI #DrugDiscovery #CRDMO #SmallMolecules

📢 I’m thrilled to share that I’ll be speaking at the #Pharmalab Congress in Düsseldorf on November 26th at 5 PM! My talk will focus on a fascinating and complex topic: 🦠“Detection and Quantification of #Endotoxic (or Not Endotoxic) #Lipopolysaccharides.” Here’s a sneak peek at what I’ll be diving into: 🔬The incredible molecular diversity of lipopolysaccharides (#LPS) 🧪A comparison of key detection and quantification methods: ▶️#LAL assay ▶️#HEK-blue #TLR-4 ▶️LC-MS/MS ▶️#MALDI-MS ️⚡Exploring the structure-activity relationship of LPS. 💡Debunking myths: Not all lipopolysaccharides are toxic! If you’re attending Pharmalab, I’d love for you to join me or my colleagues Elodie TRAN and Stephanie Harfouche! Let’s connect, exchange ideas, and dive into the science together.

Second day at the 35th International Symposium on ALS/MND... Our team is set up at Booth 11 and ready for the influx of scientists, industry experts, and members of the community at large who are about to flood through the doors of the Palais des Congres de Montreal. Don't forget to come say hello to us, we'd love to hear from you and possibly get the chance to shed more light about the possibilities that come with iPSCs in transforming ALS research and drug discovery. We are presenting a poster where we will be sharing characterization data we have done with our iPSC-derived motor neuron disease model for ALS as part of the ongoing effort to build a better human-relevant model of this disease: Poster: Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery, presented by Adele Etienne Our team will be on Booth 11 so come and talk to us if you are interested in seeing some of this characterization data and hearing how our axoCells can support your ALS research needs. We are also running a 2-min survey where you as members of the ALS community, will be able to help shape the next generation of ALS models. We value your feedback and look forward to using it to develop more sophisticated and more human-relevant iPSC-fuelled models to support ALS drug discovery. To complete this short survey, click here: https://hubs.la/Q02-RvvV0 If you won't be at this event, you can also email us your questions at operations@axolbio.com. We'd be happy to help. See you at Booth 11! Duncan Borthwick PhD #ALSMontreal #humaniPSCs #drugdiscovery #collaboration

My poster sessions are on Friday Society for Immunotherapy of Cancer (SITC). If you'd like to hear about 'LS Finder' and are interested in #spatialbiology #datascience please stop by posters 205 Development of an Algorithm (‘LS Finder’) for Identifying Lymphoid Structures, TLS and Lymphoid Aggregates, Using Immune Cell Spatial Coordinates and 1219 Analysis of PD1+ T Cells and Lymphoid Structure(TLS) Presence in Pleural Mesothelioma Using Spatial and Machine Learning Approaches. https://lnkd.in/gsevcGMD